Prefrontal Cortex Deep Brain Stimulation Improves Fear and Anxiety-Like Behavior and Reduces Basolateral Amygdala Activity in a Preclinical Model of Posttraumatic Stress Disorder.

Abstract

Deep brain stimulation (DBS) is being investigated for a number of psychiatric indications, including posttraumatic stress disorder (PTSD). Preclinical studies continue to be a cornerstone for the development of new DBS applications. We investigate whether DBS delivered to the infralimbic cortex (IL), a region involved in mechanisms of stress resiliency, may counter behavioral abnormalities in rats that present persistent extinction deficits and long-term anxiety after exposure to fear conditioning. Rats undergoing fear conditioning/extinction were segregated into weak and strong extinction groups (WE >70% or SE <30% of freezing during extinction). Following 2 weeks of DBS, animals were exposed to novel recall sessions and tested in the open field, novelty-suppressed feeding, and elevated plus maze. zif268 expression was measured in structures involved in mechanisms of fear and stress. In vivo electrophysiology was used to record activity from the basolateral amygdala (BLA). We found that DBS improved extinction deficits and anxiety-like behavior in WE animals, having no significant effects in SE rats. No major differences in absolute zif268 levels were recorded across groups. However, correlation between zif268 expression in the IL and BLA was disrupted in WE animals, a deficit that was countered by DBS treatment. Electrophysiology experiments have shown that DBS reduced BLA firing of both putative principal cells and interneurons in WE rats, with no significant differences being detected between SE and SE DBS animals. In summary, IL DBS mitigated fear, partially improved anxiety-like behavior, reversed neurocircuitry abnormalities, and reduced BLA cell firing in a preclinical model of PTSD.

• Authors: Roman Reznikov, Francis Rodriguez Bambico, Mustansir Diwan, Roger J Raymond, Mina G Nashed, José N Nobrega, Clement Hamani
• Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Neuropsychopharmacology) Vol. 43 Issue 5 Pg. 1099-1106 (04 2018) ISSN: 1740-634X [Electronic] England
• PMID: 28862251 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Early Growth Response Protein 1
• Egr1 protein, mouse

Topics

• Animals
• Anxiety (physiopathology)
• Basolateral Nuclear Complex (metabolism, physiology)
• Behavior, Animal (physiology)
• Conditioning, Psychological (physiology)
• Deep Brain Stimulation
• Early Growth Response Protein 1 (biosynthesis)
• Extinction, Psychological (physiology)
• Fear (physiology)
• Immobility Response, Tonic (physiology)
• Male
• Prefrontal Cortex (metabolism, physiology)
• Rats
• Stress Disorders, Post-Traumatic (physiopathology)